A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Clinical trial NCT00406809 · COMPLETED
Trial details
- NCT number
- NCT00406809
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2016-10-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.